Aaron welcomes Emily Kass, who’s heading into retirement after serving as executive director of Chapel Hill’s Chelsea Theater since 2018. She originally signed on as interim executive director when the theater was transitioning into a non-profit, but then stayed on for nearly a decade – guiding the theater through COVID-19, a massive renovation, and more.
The Chelsea Theater is one of 97.9 The Hill and Chapelboro.com’s community partners. Visit TheChelseaTheater.org for tickets, showtimes, and more information.
97.9 The Hill WCHL and Chapelboro.com are your headquarters for local news and local voices in Chapel Hill-Carrboro. Every weekday morning, 97.9 The Hill’s Aaron Keck chats with government officials, UNC scholars, business and nonprofit leaders, area musicians, and others in our community as they share their thoughts, their experience, and their expertise on the central issues of today. Click here to listen back to all of Aaron’s conversations – and tune in to “This Morning with Aaron Keck” at 7:30 a.m. on 97.9 The Hill to hear those conversations live.
You can also listen to “This Morning with Aaron Keck” on Spotify. Click here to follow Aaron and listen to all his segments, from local news to fun features to hard-hitting interviews.
Listen:
On Air Today: After Helping Save the Chelsea Theater, Emily Kass Heads Into Retirement Chapelboro.com.
Hence then, the article about on air today after helping save the chelsea theater emily kass heads into retirement was published today ( ) and is available on chapelboro ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( On Air Today: After Helping Save the Chelsea Theater, Emily Kass Heads Into Retirement )
Also on site :
- Run! I Spotted Ugg, Tory Burch and Levi's on Sale Before Amazon Prime Big Deal Days
- Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
- The Biggest Mistake People Make With Fall Mums Can Ruin the Blooms Fast—Here’s What a Gardener Says to Do Instead